首页> 外国专利> Mouse monoclonal anti-idiotype antibodies, process of their preparation, pharmaceutical preparations in which they are comprised and their use

Mouse monoclonal anti-idiotype antibodies, process of their preparation, pharmaceutical preparations in which they are comprised and their use

机译:小鼠单克隆抗独特型抗体,其制备方法,包含它们的药物制剂及其用途

摘要

In the present invention there are described mouse monoclonal anti-idiotype antibodies with properties of inner picture (Ab2) against monoclonal antibodies BR55-2 (Ab1) and pharmaceutical preparations in which they are comprised and which are intended for preventive and/or therapeutic immunization against infections caused by HIV virus, against cancer of epithelial origin and against cancer of small lung cells, as well as their use for determinations and in vitro immuno-purification. The process for preparing these antibodies is characterized in that mice are immunized with BR55-2/mouse IgG3-F(abˆ)i2-KLH conjugate, mouse spleen cells are subjected to fusion with cells of a mouse myeloma line SP 2/0 and obtained hybridoma cells producing IgG with inhibition capacity are selected. The inhibition capacity stands for inhibition of the BR55-2/mouse IgG2a antibody bond to a cellular line SKBE5 being higher than 95 percent, whereupon after purification the anti-idiotype antibodies are isolated.
机译:在本发明中,描述了具有针对单克隆抗体BR55-2(Ab1)的内在特征(Ab2)的小鼠单克隆抗独特型抗体,以及包含它们的药物制剂,所述药物制剂旨在用于预防和/或治疗性免疫针对由HIV病毒引起的感染,针对上皮来源的癌症和针对小肺细胞的癌症的感染,以及它们在测定和体外免疫纯化中的用途。制备这些抗体的方法的特征在于用BR55-2 /小鼠IgG3-F(abˆ)i2-KLH缀合物免疫小鼠,使小鼠脾细胞与小鼠骨髓瘤细胞系SP 2/0融合并获得选择产生具有抑制能力的IgG的杂交瘤细胞。抑制能力代表对高于细胞系SKBE5的BR55-2 /小鼠IgG2a抗体的抑制率高于95%,因此纯化后分离出抗独特型抗体。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号